MedPath

Effectiveness of the Neural Mobilization on Upper Limb Functionality in Patients With Acquired Brain Injury

Not Applicable
Completed
Conditions
Acquired Brain Injury
Hemiplegia and Hemiparesis
Interventions
Other: Neurodynamic
Other: Mimic group
Registration Number
NCT04652934
Lead Sponsor
Vanesa Abuín
Brief Summary

The main objective:

To determine changes in physiological and structural properties of upper limb muscles with spasticity in patients with acquired brain injury after applying neural mobilization improving their functional performance, their participation in society and quality of life.

Hypothesis:

Peripheral nerve mobilizations performed with neurodynamic techniques in upper limb in patients with acquired brain injury, generate changes at structural and physiological level, favoring the performance of daily life activities and improving the quality of life.

Detailed Description

Randomized clinical trial with blinding of the subject, the evaluator and the person analyzing the data.

In the experimental group will be performed neural mobilitazion technique, while in the sham a technique to mimic neurodynamic.

The assessment will be made by a single evaluator.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Diagnosis of acquired brain injury (hemiplegia-hemiparesis)
  • Ages between 25 and 50 years
Exclusion Criteria
  • Unable to understand and respond to verbal instructions
  • Absence of voluntary movement in the upper limb
  • Take medicine for spasticity
  • Botulinum toxin infiltration in the last 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupNeurodynamicThe Upper Limb Neurodynamic Test (ULNT1) technique described by Butler will be performed on the affected limb. This technique consists of performing shoulder depression, 90º shoulder abduction, hand, wrist and forearm in a neutral position, external rotation of the shoulder and extension of the elbow. After positioning the limb in this position, wrist flexion-extension movements will be performed smoothly and rhythmically of 20 movements every minute, for 3 minutes, three times per session with 1 minute of rest between each series.
Mimic groupMimic groupThe protocol used by Beneciuk et al. Will be used. This intervention consists of imitating NM without stressing the nervous system. It will be carried out as follow: a neutral cervical position will be maintained (0º of cervical inclination), 45º of shoulder abduction without depression, 45º of external rotation of the shoulder combined with 45º of elbow flexion with the forearm in pronation. Afterwards, 10 wrist flexion-extension movements will be performed at a rate of 6 seconds per cycle (3 seconds of flexion and 3 seconds of extension). The resistance that you will feel will stabilize when you change motion. Once the 10 cycles of movements have been carried out, a wrist flexion will be maintained for 10 seconds.
Primary Outcome Measures
NameTimeMethod
Changes in Muscle StrengthPre-intervention; Immediately after the intervention; Follow up (1 week after the intervention)

Dynamometer

Changes in Upper Limb Pain to PressurePre-intervention; Immediately after the intervention; Follow up (1 week after the intervention)

Algometer

Changes in Manual AbilityPre-intervention; Immediately after the intervention; Follow up (1 week after the intervention)

Abilhand Scale; Score 0(worse outcome)-2(better outcome)

Changes in Muscle SpasticityPre-intervention; Immediately after the intervention; Follow up (1 week after the intervention)

MAS (Modified Ashworth Scale) 0 (better outcome) - 4 (worse outcome)

Changes in Nervous ConductionPre-intervention; Immediately after the intervention; Follow up (1 week after the intervention)

Delsys Trigno Avanti (surface eMG for non-invasive assessment of muscles)

Changes in Upper Limb Pain PerceptionPre-intervention; Immediately after the intervention; Follow up (1 week after the intervention)

EVA (Visual Analog Scale) 0 (worse outcome) - 10 (better outcome)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Federico Salniccia

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath